Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | Rfc5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RFC5 mRNA | CTD | PMID:22206623 | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Dinitrochlorobenzene results in increased expression of RFC5 mRNA | CTD | PMID:21404309 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of RFC5 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RFC5 mRNA | CTD | PMID:21802500 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RFC5 mRNA | CTD | PMID:33387578 and PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RFC5 mRNA | CTD | PMID:15034205 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RFC5 mRNA | CTD | PMID:15034205 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Rfc5 (Mus musculus) | 6480464 | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of RFC5 mRNA] and AHR protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of RFC5 mRNA] | CTD | PMID:15034205 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rfc5 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RFC5 mRNA | CTD | PMID:21570461 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of RFC5 mRNA | CTD | PMID:21346803 | 2-palmitoylglycerol | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of RFC5 mRNA | CTD | PMID:37199045 | 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Oxazolone results in increased expression of RFC5 mRNA | CTD | PMID:21404309 | 4-hydroxyphenyl retinamide | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Fenretinide results in increased expression of RFC5 mRNA | CTD | PMID:28973697 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of RFC5 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of RFC5 mRNA | CTD | PMID:32763439 | all-trans-retinoic acid | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of RFC5 mRNA | CTD | PMID:15498508 and PMID:33167477 | AM-251 | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | AM 251 results in decreased expression of RFC5 mRNA | CTD | PMID:16500647 | arsenite(3-) | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | arsenite results in decreased expression of RFC5 mRNA | CTD | PMID:18929588 | arsenite(3-) | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to RFC5 mRNA] | CTD | PMID:32406909 | azathioprine | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of RFC5 mRNA | CTD | PMID:22623647 | benzo[a]pyrene | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of RFC5 mRNA | CTD | PMID:21714911 more ... | benzo[a]pyrene | increases methylation | ISO | RFC5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of RFC5 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of RFC5 mRNA | CTD | PMID:15034205 | benzo[a]pyrene | multiple interactions | ISO | Rfc5 (Mus musculus) | 6480464 | AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of RFC5 mRNA] and AHR protein promotes the reaction [Benzo(a)pyrene results in increased expression of RFC5 mRNA] | CTD | PMID:15034205 | benzo[a]pyrene | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of RFC5 mRNA | CTD | PMID:15034205 | benzo[a]pyrene | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of RFC5 mRNA | CTD | PMID:21802500 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | bis(2-chloroethyl) sulfide | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Mustard Gas results in decreased expression of RFC5 mRNA | CTD | PMID:25102026 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RFC5 mRNA | CTD | PMID:25181051 more ... | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of RFC5 mRNA | CTD | PMID:32145629 | bisphenol A | affects expression | ISO | RFC5 (Homo sapiens) | 6480464 | bisphenol A affects the expression of RFC5 mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of RFC5 mRNA and bisphenol A results in decreased expression of RFC5 protein | CTD | PMID:29275510 and PMID:37567409 | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of RFC5 mRNA | CTD | PMID:19167457 | cannabidiol | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Cannabidiol results in decreased expression of RFC5 mRNA | CTD | PMID:36519830 | carbon nanotube | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | carbon nanotube | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of RFC5 mRNA | CTD | PMID:37019170 | cisplatin | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in decreased expression of RFC5 mRNA] | CTD | PMID:21858171 | cisplatin | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of RFC5 mRNA | CTD | PMID:27594783 | cisplatin | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of RFC5 protein | CTD | PMID:20540955 | cisplatin | increases phosphorylation | ISO | Rfc5 (Mus musculus) | 6480464 | Cisplatin results in increased phosphorylation of RFC5 protein | CTD | PMID:22006019 | clozapine | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Clozapine results in increased expression of RFC5 protein | CTD | PMID:34122009 | cobalt dichloride | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of RFC5 mRNA | CTD | PMID:19376846 | copper atom | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RFC5 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RFC5 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of RFC5 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of RFC5 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of RFC5 mRNA | CTD | PMID:20106945 more ... | dibutyl phthalate | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of RFC5 mRNA | CTD | PMID:17361019 and PMID:21266533 | diethylstilbestrol | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of RFC5 mRNA | CTD | PMID:15766595 | dioxygen | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of RFC5 mRNA | CTD | PMID:26516004 | doxorubicin | affects response to substance | ISO | RFC5 (Homo sapiens) | 6480464 | RFC5 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 | doxorubicin | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of RFC5 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of RFC5 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RFC5 mRNA | CTD | PMID:19167446 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of RFC5 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | Rfc5 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RFC5 mRNA | CTD | PMID:22206623 | glyphosate | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Glyphosate results in decreased expression of RFC5 mRNA | CTD | PMID:31295307 | isoprenaline | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Isoproterenol results in decreased expression of RFC5 mRNA | CTD | PMID:21335049 | ivermectin | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of RFC5 protein | CTD | PMID:32959892 | Lasiocarpine | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of RFC5 mRNA | CTD | PMID:33884520 | manganese atom | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Manganese results in decreased expression of RFC5 mRNA | CTD | PMID:17175027 | manganese(0) | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Manganese results in decreased expression of RFC5 mRNA | CTD | PMID:17175027 | manganese(II) chloride | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | manganese chloride results in decreased expression of RFC5 mRNA | CTD | PMID:17175027 | methyl methanesulfonate | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of RFC5 mRNA | CTD | PMID:23649840 | methylseleninic acid | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | methylselenic acid results in decreased expression of RFC5 mRNA | CTD | PMID:11830524 | microcystin RR | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | microcystin RR results in increased expression of RFC5 protein | CTD | PMID:19111056 | monocrotaline | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | [CYP3A4 protein results in increased metabolism of Monocrotaline] which affects the expression of RFC5 mRNA | CTD | PMID:33884520 | N-nitrosodiethylamine | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of RFC5 mRNA | CTD | PMID:17854601 | N-nitrosodiethylamine | multiple interactions | ISO | Rfc5 (Mus musculus) | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of RFC5 mRNA] | CTD | PMID:17854601 | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of RFC5 mRNA | CTD | PMID:23358140 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RFC5 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Rfc5 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RFC5 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of RFC5 mRNA | CTD | PMID:34911549 | paclitaxel | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Paclitaxel results in decreased expression of RFC5 protein | CTD | PMID:15907983 | palbociclib | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | palbociclib results in decreased expression of RFC5 mRNA | CTD | PMID:22869556 | paracetamol | affects expression | ISO | Rfc5 (Mus musculus) | 6480464 | Acetaminophen affects the expression of RFC5 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RFC5 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of RFC5 mRNA | CTD | PMID:22230336 | pentachlorophenol | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of RFC5 mRNA | CTD | PMID:23892564 | perfluorooctanoic acid | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of RFC5 protein | CTD | PMID:26879310 | phorbol 13-acetate 12-myristate | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of RFC5 mRNA | CTD | PMID:19031421 | piroxicam | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in decreased expression of RFC5 mRNA] | CTD | PMID:21858171 | piroxicam | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Piroxicam results in decreased expression of RFC5 mRNA | CTD | PMID:21858171 | propiconazole | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | propiconazole results in decreased expression of RFC5 mRNA | CTD | PMID:21278054 | resveratrol | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of RFC5 mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of RFC5 mRNA | CTD | PMID:19167446 and PMID:23557933 | riddelliine | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | [CYP3A4 protein results in increased metabolism of riddelliine] which results in decreased expression of RFC5 mRNA | CTD | PMID:33884520 | rotenone | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Rotenone results in increased expression of RFC5 mRNA | CTD | PMID:18191903 | SB 431542 | multiple interactions | ISO | RFC5 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of RFC5 protein | CTD | PMID:37664457 | simvastatin | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | Simvastatin results in decreased expression of RFC5 mRNA | CTD | PMID:17428261 | sodium arsenite | increases expression | ISO | RFC5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of RFC5 mRNA | CTD | PMID:12016162 and PMID:34032870 | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of RFC5 mRNA | CTD | PMID:19281266 | tamibarotene | affects expression | ISO | RFC5 (Homo sapiens) | 6480464 | tamibarotene affects the expression of RFC5 mRNA | CTD | PMID:15498508 | tetrachloromethane | affects expression | ISO | Rfc5 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of RFC5 mRNA | CTD | PMID:17484886 | tetrachloromethane | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of RFC5 mRNA | CTD | PMID:31919559 | thapsigargin | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Thapsigargin results in decreased expression of RFC5 protein | CTD | PMID:24648495 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of RFC5 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of RFC5 mRNA | CTD | PMID:23557971 | toluene 2,4-diisocyanate | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | Toluene 2 and 4-Diisocyanate results in increased expression of RFC5 mRNA | CTD | PMID:21404309 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RFC5 mRNA | CTD | PMID:25729387 | trimellitic anhydride | increases expression | ISO | Rfc5 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of RFC5 mRNA | CTD | PMID:19042947 | troglitazone | decreases expression | ISO | RFC5 (Homo sapiens) | 6480464 | troglitazone results in decreased expression of RFC5 mRNA | CTD | PMID:19140230 | trovafloxacin | decreases expression | ISO | Rfc5 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of RFC5 mRNA | CTD | PMID:35537566 | vincaleukoblastine | affects response to substance | ISO | RFC5 (Homo sapiens) | 6480464 | RFC5 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | |